Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small molecules

28 Jun 2013

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiomyopathy and Myosin Studies
Share to Genetic Neurodegenerative Diseases
Share to Muscle Physiology and Disorders

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 23806903
DOI: 10.1038/ncomms3044

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Induction and reversal of myotonic dystrophy type 1 pre-mRNA splicing defects by small moleculesPMID 23806903Read ↗

Mitigating RNA Toxicity in Myotonic Dystrophy using Small MoleculesSemantic proximity Read ↗

Genetic therapies for RNA mis-splicing diseases.Semantic proximity Read ↗

Pre-mRNA splicing-associated diseases and therapiesSemantic proximity Read ↗

Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1Semantic proximity Read ↗

Therapeutics development in myotonic dystrophy type 1Semantic proximity Read ↗

Duchenne muscular dystrophy: Current treatment and emerging exon skipping and gene therapy approachSemantic proximity Read ↗

[Myotonic dystrophy: therapeutic approaches to RNA toxicity].Semantic proximity Read ↗

Splicing modulation therapy in the treatment of genetic diseasesSemantic proximity Read ↗

RNA-Targeting Splicing Modifiers: Drug Development and Screening AssaysSemantic proximity Read ↗

Splicing therapy for neuromuscular diseaseSemantic proximity Read ↗

Myotonic dystrophy, when simple repeats reveal complex pathogenic entities: new findings and future challengesSemantic proximity Read ↗

RNA Splicing Manipulation: Strategies to Modify Gene Expression for a Variety of Therapeutic OutcomesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.